{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"event-entities","count":1,"summary":{"policyEntityCount":21,"relationshipCount":31,"officialEventCount":14,"linkedEventCount":12,"unlinkedEventCount":2,"marketCount":7,"sourceCount":11,"agencyCount":4,"profileCrosswalkCount":6,"firstYear":2019,"latestYear":2026,"spanLabel":"2019-2026"},"guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","policyEntityFilters":{"policyEntity":"prime-therapeutics-llc","policyEntityMatched":true,"entityId":"pent-prime-therapeutics","slug":"prime-therapeutics-llc","name":"Prime Therapeutics LLC","role":null,"roleMatched":null},"rows":[{"id":"peel-prime-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-prime-therapeutics","entitySlug":"prime-therapeutics-llc","entityName":"Prime Therapeutics LLC","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies Prime Therapeutics among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/prime-therapeutics-llc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=prime-therapeutics-llc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"}]}